Navigation Links
Spherix Holds Annual Shareholders Meeting
Date:5/14/2008

BETHESDA, Md., May 14 /PRNewswire-FirstCall/ -- At their 2008 Annual Meeting, shareholders of Spherix Incorporated (Nasdaq: SPEX) elected the following members to the Board of Directors:

-- Douglas T. Brown, Senior VP and Manager of Corporate Banking Government

Contracting, PNC Bank

-- A. Paul Cox, Jr., Principal, Asset Protection Company

-- Claire L. Kruger, Chief Executive Officer and Chief Operating Officer,

Spherix

-- Gilbert V. Levin, Ph.D., Director of Science and Technology, Spherix

-- Robert A. Lodder, Jr., President, Spherix; and Professor, College of

Pharmacy, University of Kentucky

-- Aris Melissaratos, Senior Advisor to the President of Johns Hopkins

University

-- Robert J. Vander Zanden, Ph.D., former Vice President, R&D, Kraft Foods

International

In addition, Grant Thornton LLP was ratified as the Company's independent accountants for the year 2008.

Claire Kruger told the shareholders that Spherix management is focused and will continue to focus on the path forward necessary to bring Naturlose to market as a drug to treat Type 2 diabetes. To this end, three crucial activities are being undertaken in parallel:

1) Optimizing the efficiency and effectiveness of the clinical trial

program;

2) Evaluating the diabetes drug market potential to determine opportunity

and provide a clear understanding of our potential value;

3) Assuring supplies of tagatose, both the cGMP batches needed for the NDA

as well as a supplier to hold the Drug Master File once FDA approval

has been achieved.

At a Board of Directors meeting later the same day, the following slate of Corporate Officers was elected:

-- Paul Cox, Chairman of the Board

-- Claire Kruger, Chief Executive Officer and Chief Operating Officer

-- Robert Lodder, President

-- Robert Clayton, Interim Chief Financial Officer and Treasurer

-- Katherine Brailer, Corporate Secretary and Director of Administrative

Services

Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on October 10, 2007.

Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in biotechnology, and provides technical and regulatory consulting services to biotechnology and pharmaceutical companies.

Spherix's Internet address is http://www.spherix.com.


'/>"/>
SOURCE Spherix Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Hires Key Employees
2. Spherix Reports 2007 Financial Results
3. Spherix Reports 3rd Quarter Earnings
4. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
5. Sinovac Biotech Holds Annual General Meeting
6. New Robotic Imaging Technology Holds Promise of Improved Cancer Care
7. Vion Pharmaceuticals Holds Special Meeting of Stockholders
8. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
9. Kiwa Holds 2007 Annual Management Meetings and Employee Recognition Ceremonies in Beijing
10. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
11. CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016   BioInformant announces the February ... Research Products, Opportunities, Tools, and Technologies – Market Size, ... The first and ... cell industry, BioInformant has more than a decade of ... market, by stem cell type. This powerful 175 page ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global ... treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols and ... from around the world. , The new GSCG clinic is headed by ...
(Date:2/10/2016)... -- The Maryland House of Delegates and House Speaker ... Maryland School of Medicine Dean E. Albert Reece ... System President and CEO Robert Chrencik , MBA, ... given to the public by the leader of the ... and Mr. Chrencik for their contributions to our statewide ...
(Date:2/10/2016)... New York (PRWEB) , ... ... ... Inc. (NASDAQ: REGN) today announced that it has joined the Human Vaccines ... immunotherapies for infectious diseases and cancer. , The Human Vaccines Project ...
Breaking Biology Technology:
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of human interface ... 31, 2015. --> --> ... percent compared to the comparable quarter last year to $470.5 million. ... million, or $0.93 per diluted share. --> ... of fiscal 2016 grew 9 percent over the prior year period ...
(Date:1/25/2016)... BELL, Pa. , Jan. 25, 2016   Unisys Corporation ... recognition system at John F. Kennedy (JFK) International Airport, ... Border Protection (CBP) identify imposters attempting to enter ... do not belong to them. pilot testing of ... out initially at three terminals at JFK during January 2016. ...
(Date:1/22/2016)... January 22, 2016 ... addition of the  "Global Behavioral Biometric ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ... Behavioral Biometric Market 2016-2020"  report to ... and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ...
Breaking Biology News(10 mins):